Acetylsalicylic acid as an adjuvant therapy for schizophrenia
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the Netherlands.
In Netherlands
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting. It focuses on ADHD and currently lists participation information in Sweden.
In LundThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, and the United States.
Multiple locations, including ChandlerThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including BirminghamThis study is recruiting. It focuses on anxiety and currently lists participation information in the United States.
In LubbockThis study is recruiting. It focuses on depression and currently lists participation information in Germany.
In BielefeldThis study is recruiting. It focuses on bipolarity and currently lists participation information in Brazil.
In São PauloThis study is recruiting in the United States. It focuses on Depression.
In TampaThis study is recruiting. It focuses on anxiety and currently lists participation information in the United States.
In PhiladelphiaThis study is recruiting. It focuses on depression and currently lists participation information in Canada.
In MontrealThis study is recruiting in Spain. It focuses on Schizophrenia.
In SpainThis study is recruiting. It focuses on depression and currently lists participation information in Switzerland.
In Zurich